- Investing Ideas
- /
- U.S. Healthcare Potentially Undervalued Companies
U.S. Healthcare Potentially Undervalued Companies
UPDATED Sep 25, 2023
Companies with a Value score of at least 3, ordered by Value score
276 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENOVEnovis | US$54.16 | 1.2% | 14.6% | US$3.0b | US$68.80 | PS1.8x | E113.5% | n/a | ||
| XRAYDENTSPLY SIRONA | US$34.17 | -3.9% | 15.1% | US$7.2b | US$44.27 | PS1.8x | E99.2% | 1.6% | ||
| DOCSDoximity | US$20.16 | -2.9% | -34.4% | US$3.9b | US$26.91 | PE33x | E18.3% | n/a | ||
| BLCOBausch + Lomb | US$17.18 | -2.6% | 9.9% | US$6.0b | US$21.48 | PS1.5x | E106.7% | n/a | ||
| TCMDTactile Systems Technology | US$13.39 | -7.7% | 80.7% | US$314.1m | US$29.67 | PE882.4x | E101.8% | n/a | ||
| THCTenet Healthcare | US$69.26 | -1.1% | 36.7% | US$7.0b | US$94.00 | PE14.1x | E10.5% | n/a | ||
| IARTIntegra LifeSciences Holdings | US$38.31 | -2.4% | -10.3% | US$3.1b | US$47.20 | PE23.8x | E24.9% | n/a | ||
| GEHCGE HealthCare Technologies | US$66.48 | 0.3% | n/a | US$30.2b | US$89.17 | PE18.4x | E11.6% | 0.2% | ||
| OMIOwens & Minor | US$15.91 | -3.5% | -36.7% | US$1.2b | US$20.60 | PB1.4x | E112.7% | 0% | ||
| TFXTeleflex | US$203.44 | -3.7% | -0.4% | US$9.6b | US$261.81 | PE25.9x | E14.6% | 0.7% | ||
| TDOCTeladoc Health | US$19.07 | -8.2% | -27.8% | US$3.1b | US$29.92 | PS1.2x | E117.9% | n/a | ||
| ELVElevance Health | US$454.04 | 2.6% | 1.3% | US$107.0b | US$570.16 | PE16.6x | E12.5% | 1.3% | ||
| NVSTEnvista Holdings | US$28.12 | -2.6% | -17.4% | US$4.6b | US$42.78 | PE21.1x | E17.8% | n/a | ||
| PETQPetIQ | US$19.56 | 3.5% | 138.0% | US$575.6m | US$27.67 | PB2.4x | E164.6% | n/a | ||
| AMNAMN Healthcare Services | US$83.14 | -5.0% | -19.4% | US$3.2b | US$111.57 | PE9.9x | E5.3% | n/a | ||
| LFMDLifeMD | US$4.83 | 6.9% | 151.6% | US$174.0m | US$7.50 | PS1.4x | E51.2% | n/a | ||
| HCAHCA Healthcare | US$254.52 | -0.5% | 35.9% | US$69.2b | US$317.24 | PE12x | E5.4% | 0.9% | ||
| UHSUniversal Health Services | US$128.07 | 0.5% | 42.5% | US$8.9b | US$155.86 | PE12.9x | E7.9% | 0.6% | ||
| PINCPremier | US$21.65 | -1.4% | -34.8% | US$2.6b | US$27.00 | PE14.7x | E13.3% | 3.9% | ||
| INMDInMode | US$32.41 | -4.4% | 18.9% | US$2.7b | US$55.40 | PE14.8x | E16.6% | n/a | ||
| ABTAbbott Laboratories | US$97.47 | -3.5% | -2.4% | US$169.1b | US$123.77 | PE32.9x | E11.0% | 2.1% | ||
| HCATHealth Catalyst | US$9.84 | -5.7% | 2.0% | US$560.5m | US$14.92 | PS2x | E27.5% | n/a | ||
| ZIMVZimVie | US$9.75 | -4.5% | -3.7% | US$258.7m | US$13.00 | PB0.4x | S-1.6% | n/a | ||
| SKHC.FSonic Healthcare | AU$19.47 | -0.2% | 1.5% | AU$14.5b | AU$21.74 | PE21.2x | E8.4% | 3.4% |